Peltzman Revisited: Quantifying 21st Century Opportunity Costs of FDA Regulation
收藏NBER2021-12-01 更新2025-01-04 收录
下载链接：
https://www.nber.org/papers/w29574
下载链接
链接失效反馈官方服务：
资源简介：
This paper revisits Peltzman (1973) in light of two recent opportunities to quantitatively assess tradeoffs in drug regulation. First, reduced regulatory barriers to drug manufacturing associated with the 2017 reauthorization of Generic Drug User Fee Amendments were followed by significantly more
提供机构：
美国国家经济研究局
创建时间：
2021-12-01
